ATE483806T1 - Polynukleotide, welche für mitglieder der humanen b lymphozyten-aktivierendes antigen familie kodieren, und von diesen kodierte polypeptide - Google Patents
Polynukleotide, welche für mitglieder der humanen b lymphozyten-aktivierendes antigen familie kodieren, und von diesen kodierte polypeptideInfo
- Publication number
- ATE483806T1 ATE483806T1 AT00959828T AT00959828T ATE483806T1 AT E483806 T1 ATE483806 T1 AT E483806T1 AT 00959828 T AT00959828 T AT 00959828T AT 00959828 T AT00959828 T AT 00959828T AT E483806 T1 ATE483806 T1 AT E483806T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptides encoded
- blaa
- lymphocyte
- human
- polynucleotides encoding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70532—B7 molecules, e.g. CD80, CD86
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15238399P | 1999-09-03 | 1999-09-03 | |
US17290999P | 1999-12-21 | 1999-12-21 | |
US18357800P | 2000-02-18 | 2000-02-18 | |
US09/651,200 US6429303B1 (en) | 1999-09-03 | 2000-08-30 | Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
PCT/US2000/024220 WO2001018204A1 (en) | 1999-09-03 | 2000-08-31 | Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE483806T1 true ATE483806T1 (de) | 2010-10-15 |
Family
ID=27387243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00959828T ATE483806T1 (de) | 1999-09-03 | 2000-08-31 | Polynukleotide, welche für mitglieder der humanen b lymphozyten-aktivierendes antigen familie kodieren, und von diesen kodierte polypeptide |
Country Status (7)
Country | Link |
---|---|
US (2) | US6429303B1 (de) |
EP (1) | EP1220906B1 (de) |
JP (1) | JP2003516719A (de) |
AT (1) | ATE483806T1 (de) |
AU (1) | AU782101B2 (de) |
CA (1) | CA2383788A1 (de) |
WO (1) | WO2001018204A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2389916A1 (en) * | 1999-09-03 | 2001-03-15 | Human Genome Sciences, Inc. | B7-like polynucleotides, polypeptides, and antibodies |
ATE385504T1 (de) | 2000-06-06 | 2008-02-15 | Bristol Myers Squibb Co | Nukleinsäuren und polypeptide, die sich auf b7 beziehen und ihre verwendungen zur immunmodulierung |
US20030031675A1 (en) * | 2000-06-06 | 2003-02-13 | Mikesell Glen E. | B7-related nucleic acids and polypeptides useful for immunomodulation |
AU2001286205A1 (en) * | 2000-09-12 | 2002-03-26 | Kirin Beer Kabushiki Kaisha | Novel dendritic cell wall membrane and use thereof |
US20030039999A1 (en) * | 2001-05-25 | 2003-02-27 | Amgen, Inc. | B7 related protein-2 molecules and uses thereof |
AU2002368044A1 (en) * | 2001-06-22 | 2004-04-19 | Maxygen, Inc. | Co-stimulatory molecules |
EP1423402A4 (de) * | 2001-08-02 | 2006-07-05 | Lilly Co Eli | Neue polypeptidanaloga und -fusionsprodukte und deren verwendung |
EP1565489B1 (de) | 2002-06-19 | 2010-11-17 | Raven Biotechnologies, Inc. | Internalisierende Antikörper spezifisch für das RAAG10 Zelloberflächenziel |
US7732131B2 (en) * | 2004-08-03 | 2010-06-08 | Innate Pharma S.A. | Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor |
NZ568015A (en) | 2005-12-08 | 2012-03-30 | Medarex Inc | Human monoclonal antibodies to O8E |
AU2007325872B2 (en) * | 2006-11-08 | 2012-12-13 | Macrogenics West, Inc. | TES7 and antibodies that bind thereto |
EP3381937A3 (de) | 2009-08-13 | 2018-10-31 | The Johns Hopkins University | Verfahren zur modulierung der immunfunktion |
US9150656B2 (en) | 2010-03-04 | 2015-10-06 | Macrogenics, Inc. | Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof |
US8802091B2 (en) | 2010-03-04 | 2014-08-12 | Macrogenics, Inc. | Antibodies reactive with B7-H3 and uses thereof |
DE102012215962A1 (de) * | 2012-09-10 | 2014-03-13 | Robert Bosch Gmbh | Steuereinrichtung und Verfahren zum Ermitteln des Rotorwinkels einer Synchronmaschine |
US9487587B2 (en) | 2013-03-05 | 2016-11-08 | Macrogenics, Inc. | Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof |
US10273281B2 (en) | 2015-11-02 | 2019-04-30 | Five Prime Therapeutics, Inc. | CD80 extracellular domain polypeptides and their use in cancer treatment |
KR102514317B1 (ko) | 2016-04-15 | 2023-03-27 | 마크로제닉스, 인크. | 신규 b7-h3-결합 분자, 그것의 항체 약물 콘쥬게이트 및 그것의 사용 방법 |
KR20190139216A (ko) | 2017-04-28 | 2019-12-17 | 파이브 프라임 테라퓨틱스, 인크. | Cd80 세포외 도메인 폴리펩티드를 이용한 치료 방법 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
US5116742A (en) | 1986-12-03 | 1992-05-26 | University Patents, Inc. | RNA ribozyme restriction endoribonucleases and methods |
US5328470A (en) | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
PT1490386E (pt) | 1998-03-10 | 2008-11-24 | Genentech Inc | Novos polipéptidos e ácidos nucleicos que os codificam |
AU4640600A (en) | 1999-05-11 | 2000-11-21 | Eli Lilly And Company | Amyloid precursor protein protease and related nucleic acid compounds |
-
2000
- 2000-08-30 US US09/651,200 patent/US6429303B1/en not_active Expired - Fee Related
- 2000-08-31 AU AU71086/00A patent/AU782101B2/en not_active Ceased
- 2000-08-31 EP EP00959828A patent/EP1220906B1/de not_active Expired - Lifetime
- 2000-08-31 AT AT00959828T patent/ATE483806T1/de not_active IP Right Cessation
- 2000-08-31 CA CA002383788A patent/CA2383788A1/en not_active Abandoned
- 2000-08-31 JP JP2001521740A patent/JP2003516719A/ja active Pending
- 2000-08-31 WO PCT/US2000/024220 patent/WO2001018204A1/en active IP Right Grant
-
2007
- 2007-11-20 US US11/943,501 patent/US7968680B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7968680B2 (en) | 2011-06-28 |
CA2383788A1 (en) | 2001-03-15 |
US6429303B1 (en) | 2002-08-06 |
WO2001018204A1 (en) | 2001-03-15 |
EP1220906A1 (de) | 2002-07-10 |
AU782101B2 (en) | 2005-07-07 |
EP1220906B1 (de) | 2010-10-06 |
AU7108600A (en) | 2001-04-10 |
JP2003516719A (ja) | 2003-05-20 |
US20090047217A1 (en) | 2009-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE483806T1 (de) | Polynukleotide, welche für mitglieder der humanen b lymphozyten-aktivierendes antigen familie kodieren, und von diesen kodierte polypeptide | |
WO2001092523A3 (en) | Human polynucleotides and polypeptides encoded thereby | |
WO2000058473A3 (en) | Nucleic acids including open reading frames encoding polypeptides; 'orfx' | |
WO2001007595A3 (en) | Novel fibroblast growth factor and nucleic acids encoding same | |
WO2000053742A3 (en) | Polynucleotides and proteins encoded thereby | |
MXPA03006218A (es) | Receptor de citosina tipo 2 y acidos nucleicos que codifican para lo mismo. | |
WO2001036645A3 (en) | Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same | |
WO2001049729A3 (en) | Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use | |
WO2001074856A3 (en) | Wnt-7b-like polypeptides and nucleic acids encoding same | |
EA199900941A1 (ru) | БЕЛКИ, СВЯЗЫВАЮЩИЕСЯ С β-АМИЛОИДНЫМ ПЕПТИДОМ И КОДИРУЮЩИЕ ИХ ПОЛИНУКЛЕОТИДЫ | |
WO2003025147A3 (en) | Novel polynucleotides and proteins encoded thereby | |
WO2000061754A3 (en) | Human proteins and polynucleotides encoding them | |
WO2002002625A3 (en) | Novel fibroblast growth factors and nucleic acids encoding same | |
WO2001062928A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2001070978A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2001061009A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2001036638A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2001044473A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2000070046A3 (en) | Secreted polypeptides and corresponding polynucleotides | |
WO2001023561A3 (en) | Novel polynucleotides encoding proteins containing thrombospondin type 1 repeats | |
WO2001068851A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2003040345A3 (en) | Type 2 cytokine receptor and nucleic acids encoding same | |
WO2001032874A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2001023572A3 (en) | Polynucleotides and polypeptides encoded thereby | |
WO2002014348A3 (en) | Glycoproteins and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |